Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the Un-audited Financial Results for the Quarter ended 30th September, 2026 and declaration of Second Interim Dividend, if any